跳转至内容
Merck
  • Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project.

Recent intervention trials in hypertension initiated in Sweden--HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project.

Clinical and experimental hypertension (New York, N.Y. : 1993) (1999-07-28)
L Hansson
摘要

In 1998 the final results were presented of two large intervention trials in hypertension, the Hypertension Optimal Treatment Study (HOT) and the Captopril Prevention Project (CAPPP). Both were initiated from Sweden although the HOT Study was conducted in 26 countries worldwide and the CAPPP Study in Finland and Sweden. The HOT and CAPPP trials and their principal results will be reviewed briefly here. In addition a brief up-date will be provided of three ongoing intervention trials in hypertension that were also initiated from Sweden: the Swedish Trial in Old Patients with Hypertension-2 (STOP-Hypertension-), the Nordic Diltiazem (NORDIL) Study and the Study on Cognition and Prognosis in Elderly Hypertensives (SCOPE).

材料
货号
品牌
产品描述

Sigma-Aldrich
卡托普利, ≥98% (HPLC), powder
USP
卡托普利, United States Pharmacopeia (USP) Reference Standard
Supelco
卡托普利, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
卡托普利, meets USP testing specifications
卡托普利, European Pharmacopoeia (EP) Reference Standard
卡托普利, European Pharmacopoeia (EP) Reference Standard